IXICO plc (LON:IXI – Get Free Report) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 11.29 and traded as high as GBX 12. IXICO shares last traded at GBX 11.64, with a volume of 4,244 shares traded.
IXICO Stock Performance
The company has a debt-to-equity ratio of 3.32, a quick ratio of 4.90 and a current ratio of 2.85. The firm’s 50 day simple moving average is GBX 11.29 and its 200-day simple moving average is GBX 11.56. The company has a market cap of £10.78 million, a price-to-earnings ratio of -4.99, a PEG ratio of -0.38 and a beta of 0.86.
IXICO (LON:IXI – Get Free Report) last issued its earnings results on Tuesday, December 9th. The company reported GBX (1.85) EPS for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. On average, sell-side analysts predict that IXICO plc will post -289.3584879 EPS for the current year.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
See Also
- Five stocks we like better than IXICO
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- First Time Since 2007: All Warnings Active
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
